| Efficacy of non-invasive brain stimulation on cognitive functioning in brain disorders: a meta-analysis MJ Begemann, BA Brand, B Ćurčić-Blake, A Aleman, IE Sommer Psychological medicine 50 (15), 2465-2486, 2020 | 191 | 2020 |
| Estrogens in schizophrenia: progress, current challenges and opportunities BA Brand, JN de Boer, IEC Sommer Current opinion in psychiatry 34 (3), 228-237, 2021 | 68 | 2021 |
| Antipsychotic medication for women with schizophrenia spectrum disorders BA Brand, YRA Haveman, F De Beer, JN De Boer, P Dazzan, ... Psychological Medicine 52 (4), 649-663, 2022 | 46 | 2022 |
| Towards better care for women with schizophrenia-spectrum disorders BA Brand, JN de Boer, P Dazzan, IE Sommer The Lancet Psychiatry 9 (4), 330-336, 2022 | 29 | 2022 |
| Women with schizophrenia-spectrum disorders after menopause: a vulnerable group for relapse IE Sommer, BA Brand, S Gangadin, A Tanskanen, J Tiihonen, H Taipale Schizophrenia Bulletin 49 (1), 136-143, 2023 | 26 | 2023 |
| Longitudinal clinical and functional outcome in distinct cognitive subgroups of first-episode psychosis: a cluster analysis PP Oomen, MJH Begemann, BA Brand, L de Haan, W Veling, S Koops, ... Psychological Medicine 53 (6), 2317-2327, 2023 | 18 | 2023 |
| Characterizing speech heterogeneity in schizophrenia-spectrum disorders. PP Oomen, JN de Boer, SG Brederoo, AE Voppel, BA Brand, FNK Wijnen, ... Journal of psychopathology and clinical science 131 (2), 172, 2022 | 13 | 2022 |
| Medication strategies in first episode psychosis patients: A survey among psychiatrists MJ Kikkert, W Veling, L de Haan, MJH Begemann, M de Koning, ... Early intervention in psychiatry 16 (2), 139-146, 2022 | 10 | 2022 |
| The direct and long-term effects of raloxifene as adjunctive treatment for schizophrenia-spectrum disorders: a double-blind, randomized clinical trial BA Brand, JN De Boer, MC Marcelis, KP Grootens, JJ Luykx, IE Sommer Schizophrenia Bulletin 49 (6), 1579-1590, 2023 | 9 | 2023 |
| Raloxifene augmentation in men and women with a schizophrenia spectrum disorder: A study protocol BA Brand, JN de Boer, SBJO Ophuis, MIE Slot, B De Wilde, KC Catthoor, ... Contemporary Clinical Trials Communications 20, 100681, 2020 | 9 | 2020 |
| Evidence-Based Recommendations for the Pharmacological Treatment of Women with Schizophrenia Spectrum Disorders BA Brand, EJM Willemse, IMH Hamers, IE Sommer Current Psychiatry Reports 25 (11), 723-733, 2023 | 2 | 2023 |
| Antipsychotic drugs for women: a narrative review and clinical guidelines JN de Boer, BA Brand, IEC Sommer Tijdschrift Voor Psychiatrie 65 (2), 87-94, 2023 | 2 | 2023 |
| The need to focus on perfectionism in suicide assessment, treatment and prevention IE Sommer, BA Brand, CCM Stuijt, DJ Touw World Psychiatry 23, 153, 2024 | | 2024 |
| Sex differences need to be considered when treating women with psychotropic drugs IE Sommer, BA Brand, CCM Stuijt, DJ Touw World Psychiatry 23 (1), 151, 2024 | | 2024 |
| Antipsychotic medication for women with schizophrenia spectrum disorders–CORRIGENDUM BA Brand, YRA Haveman, F de Beer, JN de Boer, P Dazzan, IEC Sommer Psychological Medicine 53 (10), 4832-4832, 2023 | | 2023 |
| Antipsychotica voor vrouwen: overzicht van de literatuur en praktijkadviezen JN de Boer, BA Brand, IEC Sommer Tijdschrift voor Psychiatrie, 87-94, 2023 | | 2023 |
| Vrouwen met schizofreniespectrum-stoornissen verdienen betere zorg JN de Boer, BA Brand, IEC Sommer Tijdschrift voor Psychiatrie, 500-503, 2022 | | 2022 |
| Improving care for women with schizophrenia-spectrum disorders JN de Boer, BA Brand, IEC Sommer Tijdschrift Voor Psychiatrie 64 (8), 500-503, 2022 | | 2022 |
| S57. CHARACTERIZING COGNITIVE HETEROGENEITY IN INDIVIDUALS WITH A SCHIZOPHRENIA SPECTRUM DISORDER: A CLUSTER ANALYTIC APPROACH B Brand Schizophrenia Bulletin 46 (Suppl 1), S54, 2020 | | 2020 |
Iris SommerProfessor of PsychiatryVerified email at umcg.nl
